Impact of Underlying Malignancy Status on Clinical Characteristics and Mortality in Pulmonary Mucormycosis: A Retrospective Cohort Study
Underlying malignancy independently triples 30‑day mortality in pulmonary mucormycosis. Easily available laboratory markers-neutrophil‑to‑lymphocyte ratio and alkaline phosphatase-also stratify early risk, underscoring the need for phenotype-tailored and timely antifungal management strategies.
Authors
- Po‐Yu Liu (ORCID: https://orcid.org/0000-0001-8006-4917)
- Yung-Chun Chen (ORCID: https://orcid.org/0000-0002-9946-0685)
- Ting-Kuang Yeh (ORCID: https://orcid.org/0000-0001-5540-4780)
- Chien-Hao Tseng (ORCID: https://orcid.org/0000-0003-2098-8872)
- Po-Hsiu Huang (ORCID: https://orcid.org/0009-0003-0952-5057)
- Chia-Wei Liu (ORCID: https://orcid.org/0000-0002-3880-6259)
- Hsien-Po Huang (ORCID: https://orcid.org/0009-0005-8697-1047)
- Wei-Hsuan Huang (ORCID: https://orcid.org/0000-0002-8344-0815)
Institutions
- National Yang Ming Chiao Tung University (TW)
- National Chung Hsing University (TW)
- Taichung Veterans General Hospital (TW)
- National Yang Ming Chiao Tung University (TW)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2025-11-01
- DOI
- https://doi.org/10.2147/idr.s568648
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00